Details for 2018174274
Up to date per 22.04.2026
Actions
Details for 2018174274
Granted/Registered
European Patent
23.01.2019 A
06.10.2021 B1
10.06.2009
US
18580009 P
22.09.2009
US
24483409 P
A61K 9/127 20060101AFI20181130BHEP
Owner
Arbutus Biopharma Corporation100- 8900 Glenlyon Parkway Burnaby, BC V5J 5J8CA
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
AKINC, AkinAlnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
DORKIN, Joseph, R.Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
QIN, XiaojunAlnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
CANTLEY, WilliamAlnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
MANOHARAN, MuthiahAlnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
RAJEEV, Kallanthottathil, G.Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
NARAYANANNAIR, Jayaprakash, K.Alnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
JAYARAMAN, MuthusamyAlnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
CHEN, JianxinAlnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
ANSELL, StevenAlnylam Pharmaceuticals Inc. 300 Third Street Cambridge, MA Massachusetts 02142US
Information about Fees